• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非胸腺瘤性重症肌无力的外科治疗结果

Results of surgical treatment for nonthymomatous myasthenia gravis.

作者信息

Tansel Turkan, Onursal Ertan, Barlas Semih, Tireli Emin, Alpagut Ufuk

机构信息

Department of Cardiovascular Surgery, Istanbul University School of Medicine, Capa, Istanbul 34390, Turkey.

出版信息

Surg Today. 2003;33(9):666-70. doi: 10.1007/s00595-003-2584-5.

DOI:10.1007/s00595-003-2584-5
PMID:12928842
Abstract

PURPOSE

To clarify the factors that influence improvement and remission after thymectomy for patients with nonthymomatous myasthenia gravis (MG).

METHODS

We retrospectively reviewed 204 patients with nonthymomatous MG who underwent thymectomy and anterior mediastinal dissection through a partial median sternotomy, between 1980 and 2001, and examined whether age, sex, preoperative classification, and duration of symptoms influenced their prognosis.

RESULTS

There was no perioperative or hospital mortality. The mean follow-up period was 7.2 +/- 1.2 years, with early and late postoperative remission rates of 44.6% and 73%, respectively. Seven patients died; two from pneumonia and five from causes unrelated to MG. Preoperative treatment and classification, duration of symptoms, age, and sex did not seem to have a significant influence on remission, but the response to thymectomy was greater in patients with thymic hyperplasia. Remission and improvement rates were significantly better at the end of the first year, with the same status found at the last follow-up.

CONCLUSION

Thymectomy is an effective and highly curative method of treatment for patients. with MG. It provides excellent symptomatic improvement, which is enhanced over the long term.

摘要

目的

阐明影响非胸腺瘤性重症肌无力(MG)患者胸腺切除术后病情改善和缓解的因素。

方法

我们回顾性分析了1980年至2001年间通过部分正中胸骨切开术接受胸腺切除术和前纵隔清扫术的204例非胸腺瘤性MG患者,研究年龄、性别、术前分类和症状持续时间是否影响其预后。

结果

围手术期或住院期间无死亡病例。平均随访期为7.2±1.2年,术后早期和晚期缓解率分别为44.6%和73%。7例患者死亡;2例死于肺炎,5例死于与MG无关的原因。术前治疗和分类、症状持续时间、年龄和性别似乎对缓解无显著影响,但胸腺增生患者对胸腺切除术的反应更大。第一年结束时缓解和改善率明显更好,最后一次随访时情况相同。

结论

胸腺切除术是治疗MG患者的一种有效且治愈率高的方法。它能显著改善症状,且长期效果更佳。

相似文献

1
Results of surgical treatment for nonthymomatous myasthenia gravis.非胸腺瘤性重症肌无力的外科治疗结果
Surg Today. 2003;33(9):666-70. doi: 10.1007/s00595-003-2584-5.
2
Transsternal thymectomy for myasthenia gravis: surgical outcome.经胸骨胸腺切除术治疗重症肌无力:手术结果
Ann Thorac Surg. 2006 Jan;81(1):305-8. doi: 10.1016/j.athoracsur.2005.07.050.
3
Long-term outcome of thoracoscopic extended thymectomy for nonthymomatous myasthenia gravis.非胸腺瘤性重症肌无力胸腔镜扩大胸腺切除术的长期疗效
Eur J Cardiothorac Surg. 2009 Jul;36(1):164-9. doi: 10.1016/j.ejcts.2009.02.021. Epub 2009 Mar 31.
4
Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis.异位胸腺组织对全身血清反应阳性非胸腺瘤型重症肌无力扩大胸腺切除术后临床结局的影响。
Eur J Cardiothorac Surg. 2008 Nov;34(5):1062-7. doi: 10.1016/j.ejcts.2008.07.049. Epub 2008 Aug 29.
5
Factors influencing the outcome of transsternal thymectomy for myasthenia gravis.影响重症肌无力经胸骨胸腺切除术预后的因素。
Acta Neurol Scand. 2005 Aug;112(2):108-14. doi: 10.1111/j.1600-0404.2005.00424.x.
6
Experience with programmed steroid treatment with thymectomy in nonthymomatous myasthenia gravis.非胸腺瘤性重症肌无力患者胸腺切除术后程序化类固醇治疗的经验。
Ann Thorac Surg. 2004 May;77(5):1745-50. doi: 10.1016/j.athoracsur.2003.10.039.
7
[Thymectomy in myasthenia gravis].[重症肌无力的胸腺切除术]
Pol Merkur Lekarski. 2005 Jan;18(103):41-4.
8
Transcervical-subxiphoid-videothoracoscopic "maximal" thymectomy--operative technique and early results.经宫颈-剑突下-电视胸腔镜“扩大”胸腺切除术——手术技术及早期结果
Ann Thorac Surg. 2004 Aug;78(2):404-9; discussion 409-10. doi: 10.1016/j.athoracsur.2004.02.021.
9
Outcome after transsternal radical thymectomy for myasthenia gravis: 14-year review at Ratchaburi Hospital.经胸骨根治性胸腺切除术治疗重症肌无力的疗效:叻丕府医院14年回顾
J Med Assoc Thai. 2004 Nov;87(11):1304-10.
10
Long-term evaluation of extended thymectomy with anterior mediastinal dissection for myasthenia gravis.
Surgery. 2001 Oct;130(4):774-8; discussion 778-80. doi: 10.1067/msy.2001.116674.

引用本文的文献

1
Thymus Surgery Prospectives and Perspectives in Myasthenia Gravis.重症肌无力的胸腺手术前景与展望
J Pers Med. 2024 Feb 23;14(3):241. doi: 10.3390/jpm14030241.
2
Analysis of influencing factors of postoperative myasthenic crisis in 564 patients with myasthenia gravis in a single center.单中心 564 例重症肌无力患者术后肌无力危象的影响因素分析。
Thorac Cancer. 2023 Feb;14(5):517-523. doi: 10.1111/1759-7714.14774. Epub 2023 Jan 3.
3
Prevalence and risk factors of myasthenia gravis recurrence post-thymectomy.胸腺瘤切除术后重症肌无力复发的患病率和危险因素。
Neurosciences (Riyadh). 2021 Jan;26(1):4-14. doi: 10.17712/nsj.2021.1.20190041.
4
Assessment of the risks of a myasthenic crisis after thymectomy in patients with myasthenia gravis: a systematic review and meta-analysis of 25 studies.评估胸腺瘤切除术后重症肌无力患者发生肌无力危象的风险:25 项研究的系统评价和荟萃分析。
J Cardiothorac Surg. 2020 Sep 29;15(1):270. doi: 10.1186/s13019-020-01320-x.
5
Effect of thymectomy in elderly patients with non-thymomatous generalized myasthenia gravis.胸腺切除术对非胸腺瘤性全身性重症肌无力老年患者的影响。
J Neurol. 2019 Apr;266(4):960-968. doi: 10.1007/s00415-019-09222-2. Epub 2019 Feb 6.
6
Thymectomy is a beneficial therapy for patients with non-thymomatous ocular myasthenia gravis: a systematic review and meta-analysis.胸腺切除术治疗非胸腺瘤型眼肌型重症肌无力患者的疗效:系统评价和荟萃分析。
Neurol Sci. 2017 Oct;38(10):1753-1760. doi: 10.1007/s10072-017-3058-7. Epub 2017 Jul 13.
7
Clinical Outcomes of Myasthenia Gravis with Thymoma and Thymic Hyperplasia Undergoing Extended Transsternal Thymectomy: A Single-Center Experience.行经胸骨正中扩大胸腺切除术的胸腺瘤和胸腺增生型重症肌无力的临床结局:单中心经验
N Am J Med Sci. 2015 Nov;7(11):503-8. doi: 10.4103/1947-2714.170608.
8
Is thymectomy in non-thymomatous myasthenia gravis of any benefit?胸腺切除术对非胸腺瘤性重症肌无力有任何益处吗?
Interact Cardiovasc Thorac Surg. 2014 Mar;18(3):381-9. doi: 10.1093/icvts/ivt510. Epub 2013 Dec 18.